Shaping the Future of Medicine: Dasher Neuroscience at the Morgan Stanley Asia AI Summit

Dasher Neuroscience is proud to lead the charge at the intersection of biotechnology and artificial intelligence. Our CEO, Jane Tseng, joined global visionaries at the Morgan Stanley Asia AI Summit to explore the transformative power of AI in life sciences.

During the panel, “AI Applications in Life Sciences: Emerging Use Cases & Investment Implications,” Jane highlighted how Dasher is leveraging cutting-edge computational intelligence to accelerate drug discovery and patient outcomes.

We sincerely thank Morgan Stanley and MUFG for the kind invitation and excellent platform for exchange. We also appreciate the support of the Golden Asia Fund co-established by ITIC and Mitsubishi UFJ Capital, which helped make this engagement possible and strengthened Taiwan–Japan collaboration in AI healthcare and life sciences.